-
New Data Reveals Decentralized Clinical Trials Linked to Improved Diverse Participation Across Many Underrepresented Demographics
28 Jan 2025 12:14 GMT
… Study of Drug Development (CSDD)’s PACT Consortium links decentralized clinical trial (DCT … research professor. “Increasing diversity in clinical trials requires a multifaceted approach rather … five to 13 times for Phase II and Phase III trials, equating …
-
60 Degrees Pharma Announces IRB Approval of Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis
28 Jan 2025 13:01 GMT
… Review Board (IRB) sanctioned Phase II clinical study.
The … -only malaria prevention drug. According to the … dreams, and anxiety. Drug Interactions Avoid co-administration … successfully conduct planned clinical trials or patient recruitment …
-
March Biosciences Receives FDA Orphan Drug Designation for MB-105, a First-in-Class CD5 CAR-T Cell Therapy, for T-Cell Lymphoma
28 Jan 2025 13:00 GMT
Company prepares to advance to Phase 2 clinical trial in early 2025 HOUSTON, Jan. … in the United States. Orphan Drug designation provides various development incentives … MB-105, the progress of clinical trials for pipeline candidates, regulatory approvals …
-
Lutris Pharma Secures $30 Million Financing To Advance The Development Of Biopharmaceutical To Improve Anti-Cancer Drug Effectiveness
28 Jan 2025 13:43 GMT
… completed enrollment in the international phase 2 trial of LUT014 in patients … of the MAP Kinase pathway.
Drugs called EGFR inhibitors can block … , small molecule currently completed a phase 2 clinical trial in metastatic colorectal cancer patients …
-
Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence
28 Jan 2025 10:30 GMT
… is seeking to streamline drug repurposing, accelerate drug discovery, optimize solid- … the precision and efficiency of clinical trial monitoring. These advancements are … to patients through its proposed Phase 2 clinical trials in auto-immune disorders, the …
-
NanoViricides Engages CRO for Phase II Clinical Trial
27 Jan 2025 12:26 GMT
… conduct a Phase II clinical trial advancing its broad-spectrum antiviral drug NV-387 further … -387, our broad-spectrum antiviral drug is poised to cause a … for this drug is now further advancing into a Phase II clinical trial stage.…
-
Clinical trial to assess long-term safety of avapritinib to treat SM
27 Jan 2025 20:12 GMT
… name Aykavit.
The new clinical trial is currently recruiting participants who … previously took part in a clinical trial sponsored by Blueprint Medicines … Drug Administration previously approved avapritinib following results of Blueprint Medicine’s Phase 2 …
-
Investornewsbreaks Nanoviricides (NYSE American: NNVC) Partners With CRO To Advance NV-387 Antiviral Drug To Phase II Trials
27 Jan 2025 19:27 GMT
… Phase II clinical trial for its broad-spectrum antiviral drug, NV-387. The host-mimetic drug … TM) class of drug candidates and the … field licenses to drugs developed in several licensed … advancing NV-387 into Phase II human clinical trials. NanoViricides' …
-
How are Antibody-Drug Conjugates Shaping the NSCLC Treatment Paradigm? With David Gerber, MD
28 Jan 2025 04:30 GMT
… evolving role of antibody-drug conjugates (ADCs) in … on findings from key clinical trials. He highlighted results from … Dr Gerber also reviewed the phase 2 HERTHENA-Lung01 trial (NCT04619004 … -mutant NSCLC and the phase 2 DESTINY-Lung02 trial (NCT04644237 …
-
Thiogenesis Receives Final EU Clearance Of CTA To Initiate Its Phase 2 Clinical Trial In MELAS
27 Jan 2025 14:17 GMT
… to commence its Phase 2 clinical trial for the treatment … Thiogenesis anticipates initiating the Phase 2 clinical trial in MELAS shortly, … of the clinical trial sites.
The Phase 2 MELAS clinical trial is a … is no currently approved drugs."
About MELAS
…